When it comes to CBN however, the case is a bit different because CBN is yet to be approved as a drug and so it does not fall under the jurisdiction of this law yet. The rule exempts products that are already being marketed as food and dietary supplements which CBN is already been marketed as. This means that since CBN is already been marketed as dietary supplements prior to FDA clinical investigation of CBN as a drug, it won’t be covered under the non-exempt drug rule. This stands sure as long as manufacturers stay clear of unapproved health claims.
A new survey conducted by Pew Research examined what is considered “morally acceptable” in 25 countries.…
The agency has quietly sent a CBD compliance and enforcement policy to the White House…
When renowned US film director Paul Thomas Anderson and production designer Florencia Martin visited the…
A new chapter has begun for Chilean politics. After defeating candidate Jeannette Jara in the…
What it became is one of the most consequential cannabis-related cases the Supreme Court has…
Cannabis moves fast. New strains appear every season, each promising louder flavors, bigger yields, or…